Prime Medicine, Inc. EBT

EBT of PRME for past 10 years: annual, quarterly and twelve month trailing (TTM) including EBT growth rates and interactive chart. Earnings before tax (EBT) measures a company's financial performance. Its calculation is revenue minus expenses, excluding taxes. EBT is a line item on a company's income statement. It shows company earnings with the cost of goods sold (COGS), interest, depreciation, general and administrative expenses, and other operating expenses deducted from gross sales.

Highlights and Quick Summary

  • EBT for the quarter ending September 30, 2023 was $-50.8 Million (a 19.98% increase compared to previous quarter)
  • Year-over-year quarterly EBT increased by 28.75%
  • Annual EBT for 2022 was $-123 Million (a -25.98% decrease from previous year)
  • Annual EBT for 2021 was $-166 Million (a 10648.74% increase from previous year)
  • Annual EBT for 2020 was $-1.54 Million (a -38.89% decrease from previous year)
  • Twelve month EBT ending September 30, 2023 was $-172 Million (a 14.4% increase compared to previous quarter)
  • Twelve month trailing EBT increased by 40.29% year-over-year
Trailing EBT for the last four month:
30 Sep '23 30 Jun '23 31 Mar '23 31 Dec '22
$-172 Million $-151 Million $-138 Million $-123 Million
Visit stockrow.com/PRME for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EBT of Prime Medicine, Inc.

Most recent EBTof PRME including historical data for past 10 years.

Interactive Chart of EBT of Prime Medicine, Inc.

Prime Medicine, Inc. EBT for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 $-50.82 $-42.35 $-39.6 – –
2022 $-39.47 $-29.14 $-29.79 $-24.37 $-122.77
2021 – – – $-18.78 $-165.85
2020 – – – – $-1.54
2019 – – – – $-2.53

Business Profile of Prime Medicine, Inc.

Sector: Healthcare
Industry: Biotechnology
© stockrow.com